Inventor · disambiguated record
Robert D. Groneberg
Also filed as: GRONEBERG ROBERT · GRONEBERG ROBERT D
21 granted patents·8 pending applications·360 citations·filing 1992–2015
95Inventor score
Top patents by PatentIndex Score
29 records- 0196US5384412ASaccharide intermediates in the formation of the calicheamicin and esperamicin oligosaccharidesSCRIPPS RESEARCH INST·Filed 1992·Granted Jan 24, 1995·111 cites·16 claims
- 0292US7005440B1Therapeutic uses of tri-aryl acid derivativesAVENTIS PHARMA GMBH·Filed 2000·Granted Feb 28, 2006·79 cites·56 claims
- 0391US6635655B1Therapeutic uses of di-aryl acid derivativesAVENTIS PHARMA GMBH·Filed 2000·Granted Oct 21, 2003·61 cites·25 claims
- 0485US7521447B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Apr 21, 2009·28 cites·33 claims
- 0583US8044083B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2007·Granted Oct 25, 2011·5 cites·12 claims
- 0683USRE40558ETherapeutic uses of di-aryl acid derivativesSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Oct 28, 2008·8 cites·42 claims
- 0781US8524702B2Substituted benzoazepines as toll-like receptor modulatorsHOWBERT JAMES JEFFRY·Filed 2010·Granted Sep 3, 2013·6 cites·20 claims
- 0880US8304407B28-substituted benzoazepines as toll-like receptor modulatorsDOHERTY GEORGE A·Filed 2012·Granted Nov 6, 2012·5 cites·20 claims
- 0979US8039639B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2011·Granted Oct 18, 2011·4 cites·1 claims
- 1078US8153622B28-substituted benzoazepines as toll-like receptor modulatorsDOHERTY GEORGE A·Filed 2006·Granted Apr 10, 2012·4 cites·22 claims
- 1178US6586467B2Preparation of phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2001·Granted Jul 1, 2003·11 cites·16 claims
- 1274US9242964B2Substituted benzoazepines as toll-like receptor modulatorsVENTIRX PHARMACEUTICALS INC·Filed 2013·Granted Jan 26, 2016·2 cites·20 claims
- 1367US7612075B2Substituted oxoazaheterocyclyl compoundsAVENTIS PHARMA INC·Filed 2003·Granted Nov 3, 2009·3 cites·15 claims
- 1466US8809538B2Piperidine-containing compounds and use thereofRODRIGUEZ MARTHA E·Filed 2010·Granted Aug 19, 2014·2 cites·6 claims
- 1565US7425631B2Compounds and methods of useAMGEN INC·Filed 2004·Granted Sep 16, 2008·2 cites·6 claims
- 1664US7199244B2Cyclic amine derivatives and methods of useARRAY BIOPHARMA INC·Filed 2004·Granted Apr 3, 2007·2 cites·48 claims
- 1763US6057369ASubstituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compoundsRHONE POULENC RORER PHARMA·Filed 1997·Granted May 2, 2000·22 cites·93 claims
- 1857US2009048224A1Compounds and methods of useAMGEN INC·Filed 2008·Application pending·0 cites
- 1955US2004180896A1P38 inhibitors and methods of use thereofFiled 2003·Application pending·0 cites
- 2051US6639023B1Fluorophenyl resin compoundsAVENTIS PHARMA INC·Filed 2000·Granted Oct 28, 2003·2 cites·68 claims
- 2146US2006270675A1Inhibitors of cholesterol ester transfer proteinGRONEBERG ROBERT D·Filed 2006·Application pending·0 cites
- 2246US2016137608A1Substituted benzoazepines as toll-like receptor modulatorsHOWBERT JAMES JEFFRY·Filed 2015·Application pending·0 cites
- 2342US7078425B2Preparation of phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2003·Granted Jul 18, 2006·0 cites·15 claims
- 2441US2014228349A15,7-substituted-imidazo[1,2-c]pyrimidinesARRAY BIOPHARMA INC·Filed 2012·Application pending·0 cites
- 2540US2009227555A2Novel Pyridine CompoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2638US6306873B1Substituted β-thiocarboxylic acidsAVENTIS PHARM PROD INC·Filed 1999·Granted Oct 23, 2001·3 cites·30 claims
- 2736US2014088085A1Substituted Benzoazepines As Toll-Like Receptor ModulatorsBURGESS LAURENCE E·Filed 2012·Application pending·0 cites
- 2835US2005282812A1Inhibitors of cholesteryl ester transfer proteinJONES Zachary·Filed 2005·Application pending·0 cites
- 2934US8962596B25,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinasesBURGESS LAURENCE E·Filed 2011·Granted Feb 24, 2015·0 cites·38 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →